NEPHROS INC (NEPH) Stock Price, Quote, News and Overview
NASDAQ:NEPH - Nasdaq - US6406714005 - Common Stock - Currency: USD
NEPH Quote, Performance and Key Statistics
3.58
+0.13 (+3.77%)
The current stock price of NEPH is 3.58 USD. In the past month the price decreased by -5.29%. In the past year, price increased by 69.67%.
NEPH Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PH | PARKER HANNIFIN CORP | 27.35 | 92.42B | ||
| ITW | ILLINOIS TOOL WORKS | 25.49 | 75.51B | ||
| OTIS | OTIS WORLDWIDE CORP | 26.12 | 39.89B | ||
| IR | INGERSOLL-RAND INC | 27.17 | 35.40B | ||
| XYL | XYLEM INC | 30.04 | 32.23B | ||
| SYM | SYMBOTIC INC | 2709 | 31.95B | ||
| DOV | DOVER CORP | 21.46 | 26.13B | ||
| SNA | SNAP-ON INC | 18.02 | 17.66B | ||
| PNR | PENTAIR PLC | 23.61 | 17.56B | ||
| FTV | FORTIVE CORP | 13.08 | 17.38B | ||
| GGG | GRACO INC | 31.21 | 14.66B | ||
| IEX | IDEX CORP | 23.74 | 13.90B |
Related stock screener links
About NEPH
Company Profile
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 31 full-time employees. The company went IPO on 2004-09-21. The firm provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
Company Info
NEPHROS INC
380 Lackawanna Pl
South Orange NEW JERSEY 07079 US
CEO: Andrew Astor
Employees: 31
Phone: 12013435202
NEPHROS INC / NEPH FAQ
What is the stock price of NEPHROS INC today?
The current stock price of NEPH is 3.58 USD. The price increased by 3.77% in the last trading session.
What is the ticker symbol for NEPHROS INC stock?
The exchange symbol of NEPHROS INC is NEPH and it is listed on the Nasdaq exchange.
On which exchange is NEPH stock listed?
NEPH stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for NEPHROS INC stock?
8 analysts have analysed NEPH and the average price target is 4.85 USD. This implies a price increase of 35.34% is expected in the next year compared to the current price of 3.58. Check the NEPHROS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NEPHROS INC worth?
NEPHROS INC (NEPH) has a market capitalization of 37.95M USD. This makes NEPH a Nano Cap stock.
How many employees does NEPHROS INC have?
NEPHROS INC (NEPH) currently has 31 employees.
What are the support and resistance levels for NEPHROS INC (NEPH) stock?
NEPHROS INC (NEPH) has a support level at 3.57. Check the full technical report for a detailed analysis of NEPH support and resistance levels.
Is NEPHROS INC (NEPH) expected to grow?
The Revenue of NEPHROS INC (NEPH) is expected to grow by 17.25% in the next year. Check the estimates tab for more information on the NEPH EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NEPHROS INC (NEPH) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NEPH, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NEPH, evaluating the profitability, health, valuation and growth aspects
- NEPHROS INC (NEPH) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NEPHROS INC (NEPH) Sales and EPS estimates to see what analysts future expectations are.
- NEPHROS INC (NEPH) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NEPHROS INC (NEPH) Insider and Institutional Ownership to learn about the owners and their transactions.
- NEPHROS INC (NEPH) Stock Chart to make your own analysis
- NEPHROS INC (NEPH) Latest news and press-releases to stay up to date.
Does NEPHROS INC (NEPH) stock pay dividends?
NEPH does not pay a dividend.
When does NEPHROS INC (NEPH) report earnings?
NEPHROS INC (NEPH) will report earnings on 2025-08-06.
What is the Price/Earnings (PE) ratio of NEPHROS INC (NEPH)?
The PE ratio for NEPHROS INC (NEPH) is 51.14. This is based on the reported non-GAAP earnings per share of 0.07 and the current share price of 3.58 USD. Check the full fundamental report for a full analysis of the valuation metrics for NEPH.
What is the Short Interest ratio of NEPHROS INC (NEPH) stock?
The outstanding short interest for NEPHROS INC (NEPH) is 0.04% of its float. Check the ownership tab for more information on the NEPH short interest.
NEPH Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to NEPH. When comparing the yearly performance of all stocks, NEPH is one of the better performing stocks in the market, outperforming 94.73% of all stocks.
NEPH Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to NEPH. While NEPH has a great health rating, there are worries on its profitability.
NEPH Financial Highlights
Over the last trailing twelve months NEPH reported a non-GAAP Earnings per Share(EPS) of 0.07. The EPS increased by 150% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.16% | ||
| ROA | 6.8% | ||
| ROE | 8.62% | ||
| Debt/Equity | 0 |
NEPH Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to NEPH. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 146997491837372900% and a revenue growth 17.25% for NEPH